- Reported transaction lines
- 2
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Podnos Yale Chief Medical Officer · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | Other transactionFiling detailsSEC transaction code J Common Stock · Direct ownership · Reported balance after transaction: 257486 · Reflects shares required to be sold pursuant to a sell-to-cover transaction in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units, mandated by the Issuer and does not reflect a discretionary trade by the Reporting Person. | 2026-11-17 | 2026-11-19 | 1,271 shares/units | SEC 4 |
| Podnos Yale Chief Medical Officer · Starling Oncology, Inc. | STLN Starling Oncology, Inc. | Other transactionFiling detailsSEC transaction code J Common Stock · Direct ownership · Reported balance after transaction: 258757 · Reflects shares required to be sold pursuant to a sell-to-cover transaction in satisfaction of tax withholding obligations in connection with the vesting of restricted stock units, mandated by the Issuer and does not reflect a discretionary trade by the Reporting Person. | 2026-11-12 | 2026-11-17 | 770 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.